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Introduction
Theoperative approach to apituitaryadenoma isguidedby the
size and location of the tumor and its relation to surrounding
anatomical structures.Thelargevariation insellar invasionand
suprasellar extension of pituitary adenomaswas recognized in
the 1970s by Hardy and Vezina1 and prompted the develop-
ment of the Hardy classification criteria to better characterize
these lesions (►Table 1).1–3 Since that time, the Hardy classi-
fication system has served as a descriptive tool for pituitary
adenomas and is often utilized in research studies.4–13
The Hardy classification comprises two subscales: one
describes the integrityof the sellar floor and invasion into the
sphenoid sinus (Grades 0–IV), whereas the other describes
the degree of suprasellar extension of the tumor (Types A–D).
Although these two subscales were described using lateral
radiographs and encephalograms, respectively, the Hardy
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Abstract Objectives The Hardy classification is used to classify pituitary tumors for clinical and
research purposes. The scale was developed using lateral skull radiographs and
encephalograms, and its reliability has not been evaluated in the magnetic resonance
imaging (MRI) era.
Design Fifty preoperative MRI scans of biopsy-proven pituitary adenomas using the
sellar invasion and suprasellar extension components of the Hardy scale were reviewed.
Setting This study was a cohort study set at a single institution.
Participants There were six independent raters.
Main Outcome Measures The main outcome measures of this study were interrater
reliability, intrarater reliability, and percent agreement.
Results Overall interrater reliability of both Hardy subscales on MRI was strong.
However, reliability of the intermediate scores was weak, and percent agreement
among raters was poor (12–16%) using the full scales. Dichotomizing the scale into
clinically useful groups maintained strong interrater reliability for the sellar invasion
scale and increased the percent agreement for both scales.
Conclusion This study raises important questions about the reliability of the original
Hardy classification. Editing the measure to a clinically relevant dichotomous scale
simplifies the rating process andmay be useful for preoperative tumor characterization
in the MRI era. Future research studies should use the dichotomized Hardy scale (sellar
invasion Grades 0–III versus Grade IV, suprasellar extension Types 0–C versus Type D).
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grading scale is still used to classify adenomas based on
magnetic resonance imaging (MRI) scans. To determine the
applicability of the Hardy scale in the era of using MRIs
in pituitary practice, we evaluated the interrater and
intrarater reliabilities of the scale. Furthermore, we evalu-
ated dichotomized versions of the subscales that are clini-
cally relevant and that may better guide future pituitary
research studies.
Methods
Patients and Raters
The specific methodology used for this study type has been
published previously.14 Briefly, 50 unique, preoperative, gado-
linium-enhanced, dedicated pituitaryMRI scanswere selected
from a prospectively maintained database of cases of biopsy-
proven pituitary adenomas; cases represented a range of
tumor sizes. Six independent raters participated in the study:
three neurosurgery residents (M.A.M., D.A.H., and J.P.S.) and
three faculty raters (two pituitary surgeons [W.L.W. and A.S.L.]
and one neuroradiologist [C.R.B.]). Each rater was given a
written and verbal description of the project and a copy of
the original article describing the Hardy classification system
for reference.1 Three raters (one faculty [A.S.L.] and two
residents [D.A.H. and J.P.S.]) participated in the intrarater
reliability portion of the study and were presented with 35
imaging studies a second time more than 4 weeks after their
initial review. This study was approved by the institutional
review board. Due to the retrospective nature of the report,
informed consent was not required.
Statistics
We determined the number of scans to be analyzed and the
number of raters to be included on the basis of a prestudy
power analysis. Numerical values were assigned to roman
numerals for grades of sellar invasion and to letters for grades
of suprasellar extension. Scanswithout suprasellar extension
were listed as not applicable for this subscale and counted as
Type 0 for the analysis (►Table 1). Pairwise Spearman’s
correlation coefficients and phi coefficients were calculated
between raters and then averaged to describe the reliability
of both subscales. A scan was considered intermediate if the
mean score of all raters for the scan was between the 25th
and 75th percentiles of the mean scale score distribution.
This resulted in a definedmean intermediate group of 2.00 to
3.15 for the sellar invasion scale and of 1.15 to 2.30 for the
suprasellar extension scale. Intrarater reliability was calcu-
lated using Spearman’s correlation coefficients.
Table 1 Description of the Hardy and Vezina classification1 and the proposed dichotomized scale
Grade/Type Description
Hardy classification grade
Sellar invasion
Grade 0 The enclosed adenoma is described as a tumor that remains within the anatomical confines of the
osteoaponeural sheath of the sella turcica. The floor of the sella is always intact.
Grade I The sella turcica is within normal limits in size (less than 16  13 mm; 208mm2) but shows a lowering of the
floor on one side or a bulging of the cortex.
Grade II The sella turcica is enlarged to various degrees but the floor remains intact.
Grade III The sella is more or less enlarged but there is a local erosion or destruction of the floor.
Grade IV The entire floor of the sella is diffusely eroded or destroyed, giving a characteristic “phantom sella” with all
the boundaries barely visible.
Suprasellar extension
Type 0a The tumor is entirely confined within the sella turcica.
Type A The suprasellar expansion bulges into the chiasmatic cistern but does not reach the floor of the anterior
third ventricle.
Type B The tumor reaches the floor of the third ventricle, giving the image of an inverse cupula of the anterior
recesses of the third ventricle.
Type C A voluminous suprasellar expansion bulges largely into the third ventricle up to the foramen of Monro.
Type D Rare aberrant expansions occur in temporal or frontal fossa.
Dichotomized Hardy classification
Sellar invasion
Grade 0–III The sellar floor remains entirely or partially intact.
Grade IV The sellar floor is completely eroded, with diffuse adenoma invasion into the sphenoid sinus.
Suprasellar extension
Type 0–C The adenoma is confined to the sella or extends superiorly to the level of the foramen of Monro.
Type D The adenoma has aberrant expansion into the temporal or frontal fossa.
aAdded for the purpose of this study.
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Wealso testeddichotomizedversions of both subscales that
representclinically relevantapplications (sellarGrades0–III vs.
Grade IV; suprasellar Types 0–C vs. Type D). The mean of the
pairwise phi coefficients between the six raterswas used as an
overall reliability for the dichotomous scale. Counts and per-
centages representing rater agreement are presented. Coeffi-
cientswere interpretedas follows:0.00 to0.19 ¼ “veryweak”;
0.20 to 0.39 ¼ “weak”; 0.40 to 0.59 ¼ “moderate”; 0.60 to
0.79 ¼ “strong”; and 0.80 to 1.00 ¼ “very strong.”All calcula-
tionswereperformedbyadedicatedbiostatistician (K.C.)using
SPSS Statistics for Windows, Version 22 (IBM Corp.).
Results
Interrater Reliability
Sellar Invasion
Overall interrater reliability for the full-scale sellar invasion
rating was strong (0.69; 95% confidence interval [CI], 0.51–0.81)
(►Table 2). When examined separately, reliability of the
intermediate scores was very weak (0.15; 95% CI,  0.28 to
0.53), whereas the reliability of the scale ends (i.e., mean
Grades0–IV)wasverystrong (0.82;95%CI, 0.63–0.91).When
the scale was dichotomized into clinically useful groups of
the lesions likely to have completely eroded the sella (Grade
IV) versus those with no erosion or lesser degrees of erosion
(Grades 0–III), the reliability remained strong (0.62; 95% CI,
0.41–0.76) and the percent agreement among all raters
improved from 16% (8/50 cases) for the full scale to 64%
(32/50 cases) for the dichotomous scale (►Fig. 1).
Suprasellar Extension
Overall interrater reliability for the full-scale suprasellar
extension rating was strong (0.78; 95% CI, 0.65–0.87). When
the intermediate scores were examined separately, the relia-
bility was weak (0.35; 95% CI,  0.06 to 0.66); however, the
reliabilityof thescale endswasstrong (0.86;95%CI,0.71–0.94).
The scale was dichotomized into clinically useful groups of
Fig. 1 Percent agreement for the (A) sellar and (B) suprasellar scales by training level. (Used with permission from Barrow Neurological Institute,
Phoenix, Arizona, United States.)
Table 2 Interrater reliability: all raters
Scale Sellar invasiona Suprasellar extensionb
Reliability (95% CI) Percent agreement Reliability (95% CI) Percent agreement
Full scale 0.69 (0.51–0.81) 8/50 (16%) 0.78 (0.65–0.87) 6/50 (12%)
Intermediate scores 0.15 ( 0.28 to 0.53) 1/23 (4%) 0.35 ( 0.06 to 0.66) 3/24 (13%)
Scale ends 0.82 (0.63–0.91) 7/27 (26%) 0.86 (0.71–0.94) 3/26 (12%)
Dichotomous scale 0.62 (0.41–0.76) 32/50 (64%) 0.30 (0.03–0.54) 42/50 (84%)
Abbreviation: CI, confidence interval.
aFull scale: Grades 0–IV. Dichotomous scale: Grades 0–III versus Grade IV.
bFull scale: Types 0–D. Dichotomous scale: Types 0–C versus Type D.
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lesions with extension into the frontal or temporal fossa
(Type D) versus those with lesser degrees of extension (Types
0–C), which would influence approach selection (craniotomy
vs. transsphenoidal approach). The percent agreement among
all raters increased from 12% (6/50 cases) for the full scale to
84% (42/50) for the dichotomous scale. The reliability of the
dichotomous scale was weak (0.30; 95% CI, 0.03–0.54); how-
ever, this was attributed to minimal variability in the sample
(i.e., relatively few scans were rated D vs. A–C).
Training Level
Sellar Invasion
Overall, the differences by training level in interrater relia-
bility for sellar invasion were not significant (►Table 3).
Similar reliability emerged between faculty and resident
raters for the full scale with all 50 MRI scans included
(0.67 vs. 0.68, respectively; p ¼ 0.93), for the intermediate
scores only (0.14 vs. 0.13; p ¼ 0.97), and for the end scores
only (0.73 vs. 0.86; p ¼ 0.22). For the dichotomous scale, the
difference between faculty (0.58) and resident (0.62) relia-
bility was also not statistically significant (p ¼ 0.76).
Suprasellar Extension
Faculty versus resident reliability on suprasellar extension
grading was not significantly different for the full scale (0.80
vs. 0.78, respectively; p ¼ 0.79), for the intermediate scores
only (0.27 vs. 0.49; p ¼ 0.41), or for the scale-end scores only
(0.85 vs. 0.86; p ¼ 0.90). For the dichotomous scale, relia-
bility for faculty raters (0.51) was significantly higher than
resident raters (0.15) (p ¼ 0.046).
Intrarater Reliability
Intrarater reliability was measured by having three raters—
one faculty physician and two residents—provide sellar and
suprasellar ratings for 35 scans at two separate time points.
Intrarater reliability was in the strong range for the full sellar
invasion and suprasellar extension scales for all raters
(►Table 4). When the scale was collapsed to a dichotomous
measure, intrarater reliability remained in the strong
range for the faculty physician. Intrarater reliability was
Table 3 Interrater reliability by training level
Scale and raters Sellar invasiona Suprasellar extensionb
Reliability (95% CI) Percent agreement Reliability (95% CI) Percent agreement
Full scale
Faculty raters 0.67 (0.48–0.80) 9/50 (18%) 0.80 (0.68–0.88) 19/50 (38%)
Resident raters 0.68 (0.49–0.80) 22/50 (44%) 0.78 (0.64–0.87) 14/50 (28%)
Intermediate scores
Faculty raters 0.14 ( 0.29 to 0.52) 2/23 (9%) 0.27 ( 0.15 to 0.61) 13/24 (54%)
Resident raters 0.13 ( 0.30 to 0.52) 9/23 (39%) 0.49 (0.11–0.75) 9/24 (38%)
Scale ends
Faculty raters 0.73 (0.49–0.87) 7/27 (26%) 0.85 (0.70–0.93) 6/26 (23%)
Resident raters 0.86 (0.71–0.95) 13/27 (48%) 0.86 (0.70–0.95) 3/26 (12%)
Dichotomous scale
Faculty raters 0.58 (0.36–0.74) 36/50 (72%) 0.51 (0.27–0.69) 43/50 (86%)
Resident raters 0.62 (0.41–0.77) 36/50 (72%) 0.15 (–0.22–0.48) 45/50 (90%)
Abbreviation: CI, confidence interval.
aFull scale: Grades 0–IV. Dichotomous scale: Grades 0–III versus Grade IV.
bFull scale: Types 0–D. Dichotomous scale: Types 0–C versus Type D.
Table 4 Intrarater reliability of Hardy scales
Scale and raters Reliability
(95% CI)
Percent
agreement
Sellara full scale
Faculty rater 0.78 (0.60–0.88) 25/35 (71%)
Resident rater 1 0.79 (0.61–0.89) 22/35 (63%)
Resident rater 2 0.68 (0.45–0.83) 24/35 (69%)
Sellara dichotomous scale
Faculty rater 0.88 (0.77–0.94) 34/35 (97%)
Resident rater 1 0.49 (0.19–0.71) 26/35 (74%)
Resident rater 2 0.65 (0.40–0.81) 30/35 (86%)
Suprasellarb full scale
Faculty rater 0.86 (0.74–0.93) 23/35 (66%)
Resident rater 1 0.90 (0.80–0.95) 25/35 (71%)
Resident rater 2 0.85 (0.72–0.92) 29/35 (83%)
Suprasellarb dichotomous scale
Faculty rater 0.80 (0.64–0.90) 34/35 (97%)
Resident rater 1 1 (1–1) 35/35 (100%)
Resident rater 2 0.36 (0.04–0.62) 32/35 (91%)
Abbreviation: CI, confidence interval.
aFull scale: Grades 0–IV. Dichotomous scale: Grades 0–III versus Grade IV.
bFull scale: Types 0–D. Dichotomous scale: Types 0–C versus Type D.
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stable to decreased for resident raters with dichotomization;
however, percent agreement was improved.
Discussion
Thepreoperative characterizationofpituitaryadenomashelps
guide surgical planning, approach selection, preoperative
patient counseling, and intraoperative decision making. The
Hardy classification of sellar invasion and suprasellar exten-
sion of pituitary adenomas,which is based on radiographs and
encephalograms, is routinely cited in the literature and is used
to characterize lesions preoperatively and for pituitary re-
search studies.4–13 Despite tremendous advances in pituitary
imaging, theHardy systemcontinues to beused in theMRI era.
The most important measures of any grading scale are its
accuracy and its reproducibility among raters. An emphasis
on these characteristics has emerged in the neurosurgical
literature, and numerous scales have been evaluated over the
past decade in an attempt to validate their use for clinical
decision making and research.14–24 However, the reliability
of the Hardy scale has never been evaluated. In this report,
we provide the first analysis of both the interrater and
intrarater reliabilities of the Hardy scale, and we provide
an additional analysis of the effect of training level on
reliability and percent agreement on grading cases.
Our results reveal three main findings regarding preo-
perative classification using the Hardy system. First, the
reliabilities of the intermediate scores in the sellar invasion
and suprasellar extension subscales wereweak to veryweak.
Even in the MRI era, rater agreement regarding these char-
acteristics has poor reliability. For the sellar invasion scale,
raters demonstrated poor agreement on whether an ade-
noma simply expanded the sella (Grade II) or demonstrated
local erosion of the sellar floor (Grade III). For the suprasellar
extension scale, raters demonstrated poor agreement on
whether an adenoma simply bulged into the chiasmatic
cistern (Type A) or reached the floor of the third ventricle
(Type B). As a result, pituitary research studies that use these
grades for categorizing patients preoperatively must be
interpreted with caution.
The second important finding of this study is that, in both
subscales, the reliabilities of the scale endswere strong to very
strong. Thisfinding indicates that raters could reliably agree on
characteristics of a nonerosive, well-contained adenoma
(Grades 0–I, Types 0–A), as well as on a diffusely erosive
adenomawith aberrant expansion into the frontal or temporal
fossa (Grade IV, TypeD).Thisfinding is importantbecausethese
characteristics might influence approach selection (craniot-
omy vs. transsphenoidal), likelihood of achieving biochemical
remission or complete resection, and likelihood of recurrence;
these issues may be important for tracking outcomes in the
pituitary literature. Furthermore, these characterizing features
determine the likelihood of gross total resection andmayguide
the preoperative strategy for approaching these lesions.
Because lesions that fall at the scale ends require unique
consideration of approach and clinical outcomes, we proposed
a dichotomized scale that may provide a better classification
for pituitary adenomas in research studies moving forward.
Our results indicate that thepercent agreementbetween raters
significantly improves when the Hardy scale is dichotomized
into clinically useful grades for the sellar invasion and supra-
sellar extension scales (►Fig. 1). Thus, raters aremore likely to
agree on the categorization of these lesions when it comes to
preoperative grading for pituitary research studies. We pro-
pose the terminology “dichotomized Hardy scale” (sellar inva-
sion Grades 0–III vs. Grade IV and suprasellar extension Types
0–C vs. Type D) to be used for classification of pituitary
adenomas in future research studies.
Notably, the interrater reliability scores of the dichoto-
mized scales were generally lower than the reliability scores
of the full scale,which is a product of using the phi coefficient
to measure the association between two dichotomous vari-
ables versus the Spearman’s coefficient to determine the
association among three or more ordinal levels. The inter-
rater reliability of the suprasellar extension dichotomous
scale (0.30) was lower than the reliability of the full scale
(0.78); however, this finding is attributable to the very low
number of cases rated as Type D in this study and the low
variability in our sample. Given the relatively rare occurrence
of Type D lesions in practice, we believe that our sample
remains representative and that the improved percent
agreement among raters indicates that the dichotomized
scale performs better for this classification.
The third important finding of this study is the preserved
interrater reliability, as well as the intrarater reliability, of
the Hardy classification across training levels. Interrater
reliabilities for the full scale, for intermediate scores only,
and for end scores only were not significantly different
between resident raters and faculty raters (►Table 3).
Although the interrater reliability of the dichotomized su-
prasellar extension scale was significantly improved for the
faculty versus the resident raters, this analysis is limited by
the same low number of Type D cases, as detailed earlier. We
do not believe that this finding indicates a deficiency for the
resident raters, and overall these findings can be used to
argue that resident rating of preoperative MRI scans can be
reliable for use in pituitary research studies moving forward.
This study provides the first assessment of the reliability
of the Hardy classification in the MRI era; however, it is not
without limitations. First and foremost, all studies examin-
ing interrater and intrarater reliabilities are limited by their
selection of raters. We attempted tominimize this limitation
by selecting both resident and faculty raters, and we com-
pared the results of the two groups.Webelieve that including
resident raters in studies of reliability is essential, sincemany
studies may require resident evaluation of preoperative
imaging. It should be noted that this study was performed
at a high-volume pituitary center and included senior neu-
rosurgery residents (postgraduate years 3–5). A neuroradiol-
ogist and two pituitary surgeons were included to represent
the highest standard for preoperative imaging assessment.
The second major limitation of this study is the small
number of suprasellar extension Type D scans. As detailed
earlier, this small number limited the statistical analysis of
the dichotomous suprasellar extension scale, and it resulted
in artificially low reliability scores as measured by the phi
Journal of Neurological Surgery—Part B Vol. 78 No. B5/2017
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coefficient. Nonetheless, we believe that the results with the
dichotomous scale still represent an improvement over the
full scale, as evidenced by the substantial improvement in
percent agreement. A larger cohort of Type D scans should be
included in any future studies of this type.
Conclusion
Although the overall interrater and intrarater reliabilities of
the Hardy classification are acceptable, this study raises
concern about the poor reliability of the intermediates scores
in this system. Dichotomizing the sellar and suprasellar
subscales separates less invasive tumors (Grades 0–III, Types
0–C) from the most invasive tumors (Grade IV, Type D) and
significantly improves the percent agreement across these
scales in a way that is clinically meaningful. We believe a
modification of the Hardy scale is still relevant in current
pituitary practice and research, and authors of future pitui-
tary studies are encouraged to use the dichotomized Hardy
scale (sellar invasionGrades 0–III vs. Grade IVand suprasellar
extension Types 0–C vs. Type D) to improve agreement
among raters across different studies.
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